Towards Healthcare
Placental Stem Cell Therapy for Neurological Disorders Market to Grow at 18.14...

Placental Stem Cell Therapy for Neurological Disorders Market Innovations

The placental stem cell therapy for neurological disorders market is projected to grow from USD 535.63 million in 2025 to USD 2366.97 million by 2034 at a CAGR of 18.14%. The report covers segmentation by cell type, application, therapy type, product & services, and end-user. North America led with 40% revenue in 2024, while Asia Pacific is the fastest-growing region. It includes competitive analysis of top players like Pluristem Therapeutics, Celularity Inc., and Mesoblast Ltd., along with value chain, trade data, manufacturers, and supplier insights.

  • Last Updated: 16 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The placental stem cell therapy for neurological disorders market currently in 2025 records USD 535.63 million and is anticipated to grow to USD 2366.97 million by 2034, advancing at a CAGR of 18.14% from 2024 to 2034.

North America is currently leading the placental stem cell therapy for neurological disorders market share by 40% due to the rising neurological disorders.

The placental stem cell therapy for neurological disorders market includes six segments such as by cell type/lineage, by application, by product and services, by therapy type, by end-user, and by region.

Key trends include rising research in cell therapies and demand for personalized medicine.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.